Novena Global Lifecare defers listing after MOU with Yozma BioScience

Singapore

HOMEGROWN healthcare chain Novena Global Lifecare has held off its IPO plans following a recent fund injection. Instead, it is looking to list its subsidiary Novena Life Sciences probably sooner than itself.

Novena Global Lifecare had in July 2017 announced year plans to list on the Hong Kong market, but was convinced otherwise after a round of private investing and has decided to defer the listing.